Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Rindopepimut After Conventional Radiation in Children With Diffuse Intrinsic Pontine Gliomas

NCT01058850 is registered in ClinicalTrials.gov with Paul Graham Fisher as lead sponsor.

NCT NCT01058850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01058850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Rindopepimut After Conventional Radiation in Children With Diffuse Intrinsic Pontine Gliomas
Lead sponsor
Paul Graham Fisher
Phase
Phase 1
Overall status
Terminated
Start date
June 30, 2011
Completion date
September 30, 2013
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, brain stem tumors, pontine tumors